Samir Germanwala, MD, chairman of cardiology at Longview Regional, performed the procedure in the spring and said the team has placed “about 50 devices to date,” according to an Aug. 30 news release shared with Becker’s.
The FDA approved Abbott’s Aveir system, the first dual-chamber pacemaker approved by the agency, in July 2023. Dual-chamber pacemakers regulate contractions in the right ventricle and right atrium as opposed to single-chamber pacemakers, which connect to only one chamber in a patient’s heart.
Leadless pacemakers are associated with a “less restrictive and swifter” post-implantation recovery as placement avoids incision by implanting the device through a needle puncture in the groin, the release said.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
